[Articles] Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial
Sumber 柳叶刀 Lancet10 hari lalu
Ringkasan konten
Mitapivat, an oral pyruvate kinase activator, with a novel mechanism that ameliorates haemolytic anaemia, has the potential to be an effective and convenient d…
Situs ini hanya menyediakan indeks judul dan ringkasan, konten lengkap dan hak cipta sepenuhnya milik penerbit asli, silakan klik tautan asli untuk membaca.
Buka artikel asli- Saluran terkait
- Kesehatan
- Wilayah terkait
- Inggris
- Bahasa asli
- English
- Nomor entri
- health-94d31632
Comments 0 comments
No comments yet. Be the first.